DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,146,412 | +3.9% | 1,286,362 | +0.5% | 0.81% | +14.0% |
| Q2 2023 | $307,046,880 | +0.7% | 1,279,362 | +5.7% | 0.71% | -6.4% |
| Q1 2023 | $305,034,435 | +29.3% | 1,210,262 | +36.2% | 0.76% | +19.0% |
| Q4 2022 | $235,856,193 | +238.9% | 888,615 | +229.8% | 0.64% | +209.7% |
| Q3 2022 | $69,589,000 | +28.6% | 269,420 | +25.9% | 0.21% | +21.8% |
| Q2 2022 | $54,121,000 | -16.5% | 214,028 | -2.0% | 0.17% | +2.4% |
| Q1 2022 | $64,826,000 | -22.6% | 218,419 | -14.2% | 0.17% | -9.8% |
| Q4 2021 | $83,789,000 | +13.6% | 254,670 | +6.0% | 0.18% | +10.8% |
| Q3 2021 | $73,740,000 | +2.9% | 240,279 | -10.1% | 0.17% | +5.7% |
| Q2 2021 | $71,689,000 | +4.0% | 267,135 | -12.7% | 0.16% | 0.0% |
| Q1 2021 | $68,915,000 | +17.9% | 306,013 | +16.3% | 0.16% | +10.6% |
| Q4 2020 | $58,458,000 | +19.0% | 263,083 | +15.4% | 0.14% | +8.4% |
| Q3 2020 | $49,111,000 | +14.5% | 228,072 | -6.0% | 0.13% | +12.9% |
| Q2 2020 | $42,903,000 | +19.7% | 242,620 | -6.3% | 0.12% | +1.8% |
| Q1 2020 | $35,847,000 | -14.5% | 258,800 | -5.2% | 0.11% | +12.9% |
| Q4 2019 | $41,916,000 | +5.2% | 273,094 | -1.0% | 0.10% | +2.0% |
| Q3 2019 | $39,843,000 | -32.8% | 275,867 | -33.5% | 0.10% | -25.0% |
| Q2 2019 | $59,324,000 | +5.8% | 415,078 | -2.3% | 0.13% | +9.1% |
| Q1 2019 | $56,064,000 | +52.2% | 424,657 | +17.0% | 0.12% | +39.1% |
| Q4 2018 | $36,826,000 | -8.6% | 362,817 | -2.1% | 0.09% | +16.0% |
| Q3 2018 | $40,274,000 | +60.9% | 370,637 | +46.1% | 0.08% | +56.2% |
| Q2 2018 | $25,035,000 | +34.3% | 253,682 | +33.3% | 0.05% | +29.7% |
| Q1 2018 | $18,638,000 | -0.7% | 190,361 | -5.9% | 0.04% | +2.8% |
| Q4 2017 | $18,773,000 | -43.2% | 202,217 | -47.5% | 0.04% | -40.0% |
| Q3 2017 | $33,045,000 | – | 385,234 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |